|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA:
CA Cancer J Clin. 65:87–108. 2015.
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qi F, Li A, Zhao L, Xu H, Inagaki Y, Wang
D, Cui X, Gao B, Kokudo N, Nakata M, et al: Cinobufacini, an
aqueous extract from Bufo bufo gargarizans Cantor, induces
apoptosis through a mitochondria-mediated pathway in human
hepatocellular carcinoma cells. J Ethnopharmacol. 128:654–661.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang D and Bi Z: Bufalin inhibited the
growth of human osteosarcoma MG-63 cells via down-regulation of
Bcl-2/Bax and triggering of the mitochondrial pathway. Tumour Biol.
35:4885–4890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qi F, Li A, Inagaki Y, Xu H, Wang D, Cui
X, Zhang L, Kokudo N, Du G and Tang W: Induction of apoptosis by
cinobufacini preparation through mitochondria- and Fas-mediated
caspase-dependent pathways in human hepatocellular carcinoma cells.
Food Chem Toxicol. 50:295–302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma L, Song B, Jin H, Pi J, Liu L, Jiang J
and Cai J: Cinobufacini induced MDA-MB-231 cell
apoptosis-associated cell cycle arrest and cytoskeleton function.
Bioorg Med Chem Lett. 22:1459–1463. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee S, Lee Y, Choi YJ, Han KS and Chung
HW: Cyto-/genotoxic effects of the ethanol extract of Chan Su, a
traditional Chinese medicine, in human cancer cell lines. J
Ethnopharmacol. 152:372–376. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie X, Huang X, Li J, Lv X, Huang J, Tang
S and Sun Y: Efficacy and safety of Huachansu combined with
chemotherapy in advanced gastric cancer: A meta-analysis. Med
Hypotheses. 81:243–250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang J, Zhu L, Wu Z and Wang Y: Chinese
herbal medicines for induction of remission in advanced or late
gastric cancer. Cochrane Database Syst Rev (Issue 4).
CD0050962013.
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He W, Li Y, Chen X, Lu L, Tang B, Wang Z,
Pan Y, Cai S, He Y and Ke Z: MiR-494 acts as an anti-oncogene in
gastric carcinoma by targeting c-myc. J Gastroenterol Hepatol.
29:1427–1434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nip H, Dar AA, Saini S, Colden M, Varahram
S, Chowdhary H, Yamamura S, Mitsui Y, Tanaka Y, Kato T, et al:
Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Oncotarget. 7:68371–68384. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song L, Liu D, Wang B, He J, Zhang S, Dai
Z, Ma X and Wang X: MiR-494 suppresses the progression of breast
cancer in vitro by targeting CXCR4 through the Wnt/beta-catenin
signaling pathway. Oncol Rep. 34:525–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li N, Zhao X, Wang L, Zhang S, Cui M and
He J: MiR-494 suppresses tumor growth of epithelial ovarian
carcinoma by targeting IGF1R. Tumour Biol. 37:7767–7776. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen B, Hou Z, Li C and Tong Y: MiRNA-494
inhibits metastasis of cervical cancer through Pttg1. Tumour Biol.
36:7143–7149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou RP, Chen G, Shen ZL and Pan LQ:
Cinobufacin suppresses cell proliferation via miR-494 in BGC-823
gastric cancer cells. Asian Pac J Cancer Prev. 15:1241–1245. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Clemo NK, Collard TJ, Southern SL, Edwards
KD, Moorghen M, Packham G, Hague A, Paraskeva C and Williams AC:
BAG-1 is up-regulated in colorectal tumour progression and promotes
colorectal tumour cell survival through increased NF-kappaB
activity. Carcinogenesis. 29:849–857. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi F, Inagaki Y, Gao B, Cui X, Xu H,
Kokudo N, Li A and Tang W: Bufalin and cinobufagin induce apoptosis
of human hepatocellular carcinoma cells via Fas- and
mitochondria-mediated pathways. Cancer Sci. 102:951–958. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhai XF, Chen Z, Li B, Shen F, Fan J, Zhou
WP, Yang YK, Xu J, Qin X, Li LQ, et al: Traditional herbal medicine
in preventing recurrence after resection of small hepatocellular
carcinoma: A multicenter randomized controlled trial. J Integr Med.
11:90–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meng Z, Garrett CR, Shen Y, Liu L, Yang P,
Huo Y, Zhao Q, Spelman AR, Ng CS, Chang DZ, et al: Prospective
randomised evaluation of traditional Chinese medicine combined with
chemotherapy: A randomised phase II study of wild toad extract plus
gemcitabine in patients with advanced pancreatic adenocarcinomas.
Br J Cancer. 107:411–416. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong J, Zhai X, Chen Z, Liu Q, Ye H, Chen
W and Ling C: Treatment of huge hepatocellular carcinoma using
Cinobufacini injection in transarterial chemoembolization: A
retrospective study. Evid Based Complement Alternat Med: 2754542.
2016. View Article : Google Scholar
|
|
23
|
Chen Z, Chen HY, Lang QB, Li B, Zhai XF,
Guo YY, Yue XQ and Ling CQ: Preventive effects of jiedu granules
combined with cinobufacini injection versus transcatheter arterial
chemoembolization in post-surgical patients with hepatocellular
carcinoma: A case-control trial. Chin J Integr Med. 18:339–344.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang Y, Liu LS, Shen LP, Han ZF, Jian H,
Liu JX, Xu L, Li HG, Tian JH and Mao ZJ: Traditional Chinese
Medicine treatment as maintenance therapy in advanced
non-small-cell lung cancer: A randomized controlled trial.
Complement Ther Med. 24:55–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP
and Pan BR: Efficacy and safety of gemcitabine-oxaliplatin combined
with huachansu in patients with advanced gallbladder carcinoma.
World J Gastroenterol. 14:5210–5216. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu Q, Lin WD, Liao GQ, Zhang LG, Wen SQ
and Lin JY: Antiproliferative effects of cinobufacini on human
hepatocellular carcinoma HepG2 cells detected by atomic force
microscopy. World J Gastroenterol. 21:854–861. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin JQ, Wen L, Wu LC, Gao ZH, Huang G,
Wang J, Zou CY, Tan PX, Yong BC, Jia Q, et al: The glycogen
synthase kinase-3beta/nuclear factor-kappa B pathway is involved in
cinobufagin-induced apoptosis in cultured osteosarcoma cells.
Toxicol Lett. 218:129–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Wang L, Liu Z, Zu C, Xing F, Yang P,
Yang Y, Dang X and Wang K: MicroRNA-494 inhibits cell proliferation
and invasion of chondrosarcoma cells in vivo and in vitro by
directly targeting SOX9. Oncotarget. 6:26216–26229. 2015.PubMed/NCBI
|
|
29
|
Shrestha S, Hsu SD, Huang WY, Huang HY,
Chen W, Weng SL and Huang HD: A systematic review of microRNA
expression profiling studies in human gastric cancer. Cancer Med.
3:878–888. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ni W, Chen B, Zhou G, Lu C, Xiao M, Guan
C, Zhang Y, He S, Shen A and Ni R: Overexpressed nuclear BAG-1 in
human hepatocellular carcinoma is associated with poor prognosis
and resistance to doxorubicin. J Cell Biochem. 114:2120–2130. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun NF, Meng QY, Hu SY, Tian AL, Wang RH,
Liu ZX and Xu L: Correlation between the expression of the BAG-1
gene and clinicopathologic factors in colorectal cancer. J Cancer
Res Clin Oncol. 137:1419–1424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng HC, Xu XY, Xing YN, Wei ZL,
Takahashi H, Masuda S and Takano Y: Nuclear or cytoplasmic
localization of Bag-1 distinctly correlates with pathologic
behavior and outcome of gastric carcinomas. Hum Pathol. 41:724–736.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Krajewska M, Turner BC, Shabaik A,
Krajewski S and Reed JC: Expression of BAG-1 protein correlates
with aggressive behavior of prostate cancers. Prostate. 66:801–810.
2006. View Article : Google Scholar : PubMed/NCBI
|
